Nanocarriers for diagnosis and targeting of breast cancer

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Sharma, Arun ^a   Jain, Nitin ^a   Sareen, Rashmi ^a  

^a SHOOLINI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOHYDRATE; DAUNORUBICIN; DENDRIMER; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HISTONE DEACETYLASE INHIBITOR; LECTIN; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; MULTI WALLED NANOTUBE; NANOCARRIER; NANOROD; OXALIPLATIN; PACLITAXEL; POLYCAPROLACTONE; PROGESTERONE RECEPTOR; QUANTUM DOT; SINGLE WALLED NANOTUBE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; ZINC OXIDE; DIAGNOSTIC AGENT; DRUG CARRIER; NANOPARTICLE;

ADSORPTION; BREAST CANCER; BREAST CARCINOMA; CANCER STAGING; CANCER STEM CELL; CYTOTOXICITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG TARGETING; ENDOCYTOSIS; HUMAN; INTRADUCTAL CARCINOMA; LYMPHATIC DRAINAGE; MICELLE; NONHUMAN; PAGET NIPPLE DISEASE; PLASMA HALF LIFE; REVIEW; TUMOR MICROENVIRONMENT; BREAST TUMOR; FEMALE; BREAST NEOPLASMS; DIAGNOSTIC USE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; NANOPARTICLES;

EID: 84880140439     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/960821     Document Type: Review

References (75)

1. Tanaka T., Decuuzzi P., Ferrai M., Nanotechnology for breast cancer therapy. Biomed Micro Devices 2009 11 1 49 63
2. Nie S., Xing Y., Kim G. J., Nanotechnology application in cancer. Annual Review of Biomedical Engineering 2007 9 257 288
3. Sinha R., Kim G. J., Nie S., Shin D. M., Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Molecular Cancer Therapeutics 2006 5 8 1909 1917 2-s2.0-33748344520 10.1158/1535-7163.MCT-06-0141
4. Brinton L. A., Sherman M. E., Carreon J. D., Anderson W. F., Recent trends in breast cancer among younger women in the United States. Journal of the National Cancer Institute 2008 100 22 1643 1648 2-s2.0-56749104678 10.1093/jnci/djn344
5. Leary O., Sheaffer, Phillips, Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000 2006 National Cancer Institute (NIH). Pub. No. 06-5767
6. Haffty B. G., Yang Q., Reiss M., Kearney T., Higgins S. A., Weidhaas J., Harris L., Hait W., Toppmeyer D., Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. Journal of Clinical Oncology 2006 24 36 5652 5657 2-s2.0-34247381115 10.1200/JCO.2006.06. 5664
7. Shackleton M., Quintana E., Fearon E. R., Morrison S. J., Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009 138 5 822 829 2-s2.0-69449096005 10.1016/j.cell.2009.08.017
8. Huang X., El-Sayed I. H., Qian W., El-Sayed M. A., Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. Journal of the American Chemical Society 2006 128 6 2115 2120 2-s2.0-33244457595 10.1021/ja057254a
9. Patil S. J., Zajac A., Zhukov T., Bhansali S., Ultrasensitive electrochemical detection of cytokeratin-7, using Au nanowires based biosensor. Sensors and Actuators B 2008 129 2 859 865 2-s2.0-38949150406 10.1016/j.snb.2007.09.080
10. Nie S., Xing Y., Kim G. J., Nanotechnology application in cancer. Annual Review of Biomedical Engineering 2007 9 257 288
11. Yu W. W., Qu L. H., Guo W. Z., Peng X. G., Experimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystals. Chemistry of Materials 2003 15 14 2854 2860 2-s2.0-0037816199 10.1021/cm034081k
12. Cho K., Wang X., Nie S., Chen Z., Shin D. M., Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Research 2008 14 5 1310 1316 2-s2.0-40949127319 10.1158/1078-0432.CCR-07-1441
13. Sinha R., Kim G. J., Nie S., Shin D. M., Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Molecular Cancer Therapeutics 2006 5 8 1909 1917 2-s2.0-33748344520 10.1158/1535-7163.MCT-06-0141
14. Geels P., Eisenhauer E., Bezjak A., Zee B., Day A., Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. Journal of Clinical Oncology 2000 18 12 2395 2405 2-s2.0-0034101194
15. Jones A., Harris A. L., New developments in angiogenesis: a major mechanism for tumor growth and target for therapy. Cancer Journal from Scientific American 1998 4 4 209 217 2-s2.0-0031927962
16. Moghimi S. M., Hunter A. C., Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends in Biotechnology 2000 18 10 412 420 2-s2.0-0034308222 10.1016/S0167-7799(00)01485-2
17. Park E. K., Lee S. B., Lee Y. M., Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε -caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005 26 9 1053 1061 2-s2.0-4444232233 10.1016/j.biomaterials.2004.04.008
18. Maeda H., Matsumura Y., Tumoritropic and lymphotropic principles of macromolecular drugs. Critical Reviews in Therapeutic Drug Carrier Systems 1989 6 3 193 210 2-s2.0-0024839642
19. Mansour A. M., Drevs J., Esser N., Hamada F. M., Badary O. A., Unger C., Fichtner I., Kratz F., A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2. Cancer Research 2003 63 14 4062 4066 2-s2.0-0042173127
20. Nomura T., Saikawa A., Morita S., Sakaeda T., Yamashita F., Honda K., Yoshinobu Takakura Y. T., Hashida M., Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection. Journal of Controlled Release 1998 52 3 239 252 2-s2.0-0032584134 10.1016/S0168-3659(97)00185-5
21. Prabha S., Labhasetwar V., Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Molecular Pharmacology 2004 1 3 211 219 2-s2.0-22444444015
22. Kirpotin D. B., Drummond D. C., Shao Y., Shalaby M. R., Hong K., Nielsen U. B., Marks J. D., Benz C. C., Park J. W., Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Research 2006 66 13 6732 6740 2-s2.0-33746172167 10.1158/0008-5472.CAN-05-4199
23. Rawat M., Singh D., Saraf S., Saraf S., Nanocarriers: promising vehicle for bioactive drugs. Biological and Pharmaceutical Bulletin 2006 29 9 1790 1798 2-s2.0-33748353240 10.1248/bpb.29.1790
24. Gradishar W. J., Tjulandin S., Davidson N., Shaw H., Desai N., Bhar P., Hawkins M., O'Shaughnessy J., Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. Journal of Clinical Oncology 2005 23 31 7794 7803 2-s2.0-32944482677 10.1200/JCO.2005.04.937
25. Li C., Poly(L-glutamic acid)-anticancer drug conjugates. Advanced Drug Delivery Reviews 2002 54 5 695 713 2-s2.0-0037072529 10.1016/S0169-409X(02) 00045-5
26. Duncan R., The dawning era of polymer therapeutics. Nature Reviews Drug Discovery 2003 2 5 347 360 2-s2.0-0038387390 10.1038/nrd1088
27. Torchilin V. P., Micellar nanocarriers: pharmaceutical perspectives. Pharmaceutical Research 2007 24 1 1 16 2-s2.0-33845388144 10.1007/s11095-006- 9132-0
28. Adams M. L., Lavasanifar A., Kwon G. S., Amphiphilic block copolymers for drug delivery. Journal of Pharmaceutical Sciences 2003 92 7 1343 1355 2-s2.0-0038759662 10.1002/jps.10397
29. Jones M.-C., Leroux J.-C., Polymeric micelles-a new generation of colloidal drug carriers. European Journal of Pharmaceutics and Biopharmaceutics 1999 48 2 101 111 2-s2.0-0032778659 10.1016/S0939-6411(99)00039-9
30. Xue Y., Tang X., Huang J., Zhang X., Yu J., Zhang Y., Gui S., Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft- α β -poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice. Colloids and Surfaces B 2011 85 2 280 288 2-s2.0-79955668023 10.1016/j.colsurfb.2011.02.040
31. Zhang Y., Zhang H., Wang X., Wang J., Zhang X., Zhang Q., The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials 2012 33 2 679 691 2-s2.0-80055112766 10.1016/j.biomaterials.2011. 09.072
32. Liu L., Sun L., Qijie W., Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. International Journal of Pharmaceutics 2013 44 1-2 175 182
33. Weissleder R., Tung C.-H., Mahmood U., Bogdanov A. Jr., In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnology 1999 17 4 375 378 2-s2.0-0032951071 10.1038/7933
34. Chen X., Conti P. S., Moats R. A., In vivo near-infrared fluorescence imaging of integrin α v β 3 in brain tumor xenografts. Cancer Research 2004 64 21 8009 8014 2-s2.0-7444235966 10.1158/0008-5472.CAN-04-1956
35. Kim S. E., Kwon I. C., Song H. R., Park K., Insight of key factors influencing tumor targeting characteristics of Glycol Chitosan-based nanoparticles and in vivo applications. Macromolecular Research 2012 20 11 1109 1117
36. Kim K., Lee M., Park H., Kim J.-H., Kim S., Chung H., Choi K., Kim I.-S., Seong B. L., Kwon I. C., Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging. Journal of the American Chemical Society 2006 128 11 3490 3491 2-s2.0-33645403885 10.1021/ja057712f
37. Lee C. C., MacKay J. A., Fréchet J. M. J., Szoka F. C., Designing dendrimers for biological applications. Nature Biotechnology 2005 23 12 1517 1526 2-s2.0-28644434579 10.1038/nbt1171
38. Svenson S., Tomalia D. A., Dendrimers in biomedical applications- reflections on the field. Advanced Drug Delivery Reviews 2005 57 15 2106 2129 2-s2.0-28744443398 10.1016/j.addr.2005.09.018
39. Tomalia D. A., Baker H., Dewald J., Hall M., Kallos G., Martin S., Roeck J., Ryder J., Smith P., Dendritic macromolecules: synthesis of starburst dendrimers. Macromolecules 1986 19 9 2466 2468 2-s2.0-30244557628
40. Tomalia D. A., Baker H., Dewald J., Hall M., Kallos G., Martin S., Roeck J., Ryder J., Smith P., A new class of polymers: starburst dendritic macromolecules. Polymer Journal 1984 17 1 117 132 2-s2.0-0021586266
41. Newkome G. R., Yao Z.-Q., Baker G. R., Gupta V. K., Cascade molecules: a new approach to micelles. A [27]-arborol. Journal of Organic Chemistry 1985 50 11 2003 2004 2-s2.0-33845378981
42. Hawker C. J., Fréchet J. M. J., Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. Journal of the American Chemical Society 1990 112 21 7638 7647 2-s2.0-0038817081
43. Svenson S., Tomalia D. A., Dendrimers in biomedical applications- reflections on the field. Advanced Drug Delivery Reviews 2005 57 15 2106 2129 2-s2.0-28744443398 10.1016/j.addr.2005.09.018
44. Wang P., Zhao X.-H., Wang Z.-Y., Meng M., Li X., Ning Q., Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment. Cancer Letters 2010 298 1 34 49 2-s2.0-77956937217 10.1016/j.canlet.2010.06.001
45. Gupta U., Dwivedi S. K. D., Bid H. K., Konwar R., Jain N. K., Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. International Journal of Pharmaceutics 2010 393 1-2 186 197 2-s2.0-77953364108 10.1016/j.ijpharm.2010.04.002
46. Samuelson L. E., Dukes M. J., Hunt C. R., Casey J. D., Bornhop D. J., TSPO targeted dendrimer imaging agent: synthesis, characterization, and cellular internalization. Bioconjugate Chemistry 2009 20 11 2082 2089 2-s2.0-71249088415 10.1021/bc9002053
47. Khan D. R., Rezler E. M., Lauer-Fields J., Fields G. B., Effects of drug hydrophobicity on liposomal stability. Chemical Biology and Drug Design 2008 71 1 3 7 2-s2.0-37849023744 10.1111/j.1747-0285.2007.00610.x
48. New R. R. C., Liposomes: A Practical Approach 1990 1st Oxford, UK Oxford University Press
49. Rezler E. M., Khan D. R., Lauer-Fields J., Cudic M., Baronas-Lowell D., Fields G. B., Targeted drug delivery utilizing protein-like molecular architecture. Journal of the American Chemical Society 2007 129 16 4961 4972 2-s2.0-34247538373 10.1021/ja066929m
50. Khan D. R., The use of nanocarriers for drug delivery in cancer therapy. Journal of Cancer Science and Therapy 2010 2 3 58 62 2-s2.0-77954645526 10.4172/1948-5956.1000024
51. Hofheinz R.-D., Gnad-Vogt S. U., Beyer U., Hochhaus A., Liposomal encapsulated anti-cancer drugs. Anti-Cancer Drugs 2005 16 7 691 707 2-s2.0-23344439607 10.1097/01.cad.0000167902.53039.5a
52. Elbayoumi T. A., Torchilin V. P., Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice. International Journal of Pharmaceutics 2008 357 1-2 272 279 2-s2.0-42749087942 10.1016/j.ijpharm.2008.01.041
53. Gabizon A. A., Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Investigation 2001 19 4 424 436 2-s2.0-0035005359 10.1081/CNV-100103136
54. Shahun M., Soudy R., Aliabadi H. M., Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity. Biomaterials 2013 34 16 4089 4097
55. Urbinati G., Marsaud V., Plassat V., Fattal E., Lesieur S., Renoir J. M., Liposomes loaded with histane deacetylase inhibitors for breast cancer therapy. International Journal of Pharmaceutics 2010 379 1 184 193
56. Park J. W., Liposome-based drug delivery in breast cancer treatment. Breast Cancer Research 2002 4 3 95 99 2-s2.0-0036096806 10.1186/bcr432
57. Dagar S., Krishnadas A., Rubinstein I., Blend M. J., Önyüksel H., VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies. Journal of Controlled Release 2003 91 1-2 123 133 2-s2.0-0141886984 10.1016/S0168-3659(03)00242-6
58. Sahoo N. G., Bao H., Pan Y., Pal M., Kakran M., Cheng H. K. F., Li L., Tan L. P., Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chemical Communications 2011 47 18 5235 5237 2-s2.0-79954588299 10.1039/c1cc00075f
59. Lamprecht C., Liashkovich I., Neves V., Danzberger J., Heister E., Rangl M., Coley H. M., McFadden J., Flahaut E., Gruber H. J., Hinterdorfer P., Kienberger F., Ebner A., AFM imaging of functionalized carbon nanotubes on biological membranes. Nanotechnology 2009 20 43 2-s2.0-70349694341 10.1088/0957-4484/20/43/434001 434001
60. Kang B., Chang S., Dai Y., Yu D., Chen D., Cell response to carbon nanotubes: size-dependent intracellular uptake mechanism and subcellular fate. Small 2010 6 21 2362 2366 2-s2.0-78349255913 10.1002/smll.201001260
61. Lay C. L., Liu H. Q., Tan H. R., Liu Y., Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutic. Nanotechnology 2010 21 6 065101
62. Wu W., Li R., Bian X., Zhu Z., Ding D., Li X., Jia Z., Jiang X., Hu Y., Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity. ACS Nano 2009 3 9 2740 2750 2-s2.0-70349528267 10.1021/nn9005686
63. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., Dai H., Drug delivery with carbon nanotubes for in vivo cancer treatment. The Journal of Cancer Research 2008 68 16 6652 6660 2-s2.0-53049104252 10.1158/0008-5472.CAN- 08-1468
64. Chen H., Ma X., Li Z., Shi Q., Zheng W., Liu Y., Wang P., Functionalization of single-walled carbon nanotubes enables efficient intracellular delivery of siRNA targeting MDM2 to inhibit breast cancer cells growth. Biomedicine and Pharmacotherapy 2012 60 5 334 338 2-s2.0-84857679289 10.1016/j.biopha.2011.12.005
65. Avti P. K., Sitharaman B., Luminescent single-walled carbon nanotube-sensitized europium nanoprobes for cellular imaging. International Journal of Nanomedicine 2012 7 1953 1964
66. Tong L., Wei Q., Wei A., Cheng J.-X., Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. Photochemistry and Photobiology 2009 85 1 21 32 2-s2.0-58349087531 10.1111/j.1751-1097.2008.00507.x
67. Parab H. J., Chen H. M., Lai T.-C., Huang J. H., Chen P. H., Liu R.-S., Hsiao M., Chen C.-H., Tsai D.-P., Hwu Y.-K., Biosensing, cytotoxicity, and cellular uptake studies of surface-modified gold nanorods. Journal of Physical Chemistry C 2009 113 18 7574 7578 2-s2.0-67049164787 10.1021/jp9000169
68. Albanese A., Chan W. C. W., Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano 2011 5 7 5478 5489 2-s2.0-79961096067 10.1021/nn2007496
69. Wilson C. G., Sisco P. N., Goldsmith E. C., Murphy C. J., Glycosaminoglycan-functionalized gold nanorods: interactions with cardiac cells and type I collagen. Journal of Materials Chemistry 2009 19 35 6332 6340 2-s2.0-69249177097 10.1039/b902760b
70. Eghtedari M., Liopo A. V., Copland J. A., Oraevsky A. A., Motamed M., Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano Letters 2009 9 1 287 291 2-s2.0-61649110773 10.1021/nl802915q
71. Connor E. E., Mwamuka J., Gole A., Murphy C. J., Wyatt M. D., Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005 1 3 325 327 2-s2.0-25444448098 10.1002/smll.200400093
72. Xiao Y., Hong H., Matson V. Z., Gold nanorods conjugated with Doxorubicin and cRGD for combined anticancer drug delivery and Pet imaging. Thernostics 2012 2 8 757 768
73. Kishwar S., Asif M. H., Nur O., Willander M., Larsson P.-O., Intracellular ZnO nanorods conjugated with protoporphyrin for local mediated photochemistry and efficient treatment of single cancer cell. Nanoscale Research Letters 2010 5 10 1669 1674 2-s2.0-77958481479 10.1007/s11671-010-9693-z
74. Zhang H., Chen B., Jiang H., Wang C., Wang H., Wang X., A strategy for ZnO nanorod mediated multi-mode cancer treatment. Biomaterials 2011 32 7 1906 1914 2-s2.0-78650983813 10.1016/j.biomaterials.2010.11.027
75. 4 nanoparticle "nano-pearl- necklaces" for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells. Angewandte Chemie 2009 48 15 2759 2763 2-s2.0-63449129301 10.1002/anie.200805282